trending Market Intelligence /marketintelligence/en/news-insights/trending/o7_3cakvby1d5dxfvjl55w2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

STAAR Surgical plans common stock offering

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


STAAR Surgical plans common stock offering

STAAR Surgical Co. is planning a public offering of 1,739,000 common shares.

The Monrovia, Calif.-based developer of implantable eye lenses granted the underwriters an option to buy up to an additional 260,850 shares.

STAAR intends to use the net proceeds to fund its operations, which may include advancing the commercialization of its implantable Collamer lens family of products.

The company may also use the proceeds to fund pipeline research and development activities and clinical trials, fund incremental investments in automation and precision manufacturing, and capital expenditures, and for general corporate purposes, including working capital.

Canaccord Genuity is acting as the sole book-running manager for the offering.